CLINICAL_TRIALS
trial_result
· 2016-10-04
Clinical Trial Update: Study of Pembrolizumab (MK-3475) in Participants With Advanced Melanoma (MK-3475-041/KEYNOTE-041) [Phase 1]
Summary
Phase 1 study of pembrolizumab in advanced melanoma completed; results posted in 2016.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Merck Sharp & Dohme LLC | Conditions: Melanoma | Phase 1 | Status: COMPLETED | Results posted: 2016-10-04